Golden
Novartis Bioventures

Novartis Bioventures

A venture capital company with a focus on science related start-ups and products. It was founded in 1996 and has offices in both Switzerland and the United States of America.

Novartis Bioventures is a global venture capital firm that invests in products such as medical therapeutics and platforms. Sectors in which it invests include medical devices and implants, diagnostics and biomarkers research, and drug delivery and polymers. As of 2020, it has approximately $800 million under management with more than 24 portfolio companies. It has made nearly 200 investments in total and has had 51 exits. Between 1998 and 2009, Novartis Bioventures raised three funds totaling more than $720 million. 

Timeline

People

Name
Role
LinkedIn

Bart Dzikowski

Managing Director



Dr. Anja König

Global Head



Dr. Laura Brass

Managing Director



Further reading

Title
Author
Link
Type
Date

Xconomy: Intellikine Attracts Novartis, Biogen, and Others for $51M Second Round



Web

July 9, 2009

Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References